Jewish Values Investors JLens Target Israeli Company
Here's Why Teva Shares are Trending Higher Today - TipRanks.com
Teva Bonds: 8.8% Yield To Maturity Understates Upside | Nasdaq
Teva dispenses $2.6 million to resolve ERISA claims | Pensions & Investments
NuPathe acquired by Teva for $144M - Technical.ly
Report: Teva settles investor lawsuit for $420M - www.israelhayom.com
Teva Pharmaceuticals will pay $420 million in a federal case
Teva Pharmaceutical Industries Adds US$389m To Market Cap, But Investors Still Down 47% From Five Years Ago - Simply Wall St News
TEVA Pharmaceuticals sells Forest facility to private investor | WSET
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Capital Research Global Investors increases ownership in TEVJF / Teva Pharmaceutical Industries Ltd.
6 Reasons I've Been Aggressively Buying Teva Pharmaceutical Industries | The Motley Fool
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Why the Teva Pharmaceuticals Stock Rebound May Be Real | InvestorPlace
Teva Pharmaceuticals Portfolio Investments, Teva Pharmaceuticals Funds, Teva Pharmaceuticals Exits
Teva Selling $3.5 Billion of Junk Bonds to Refinance Debt - Bloomberg
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceutical Stock Could Double | Barron's
Teva Reports Earnings Tomorrow. Here's What to Expect. | Barron's
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Teva Stock Price Today | NYSE TEVA Live Ticker - Investing.com
